Predicting visceral leishmaniasis in HIV infected patients: how to screen and who to treat Instituut voor Tropische Geneeskunde
HIV has been identified as one of the emerging challenges for control of visceral leishmaniasis (VL). This problem is now especially severe in Ethiopia – a L. donovani endemic region ‐ where up to 40% of patients with VL are co‐infected with HIV. Once VL is established in HIV‐infected individuals‐ meaning that L donovani infection has evolved to the disease stage ‐ prognosis at the individual level is dire, with high rates of case fatality ...